– solution for injections 0.4 mg/ml 1 ml ampoules 10 units per pack
Included in the List of Vital and Essential Drugs
Registration number: LP-000266
Pharmacotherapeutic group: opioid receptor antagonist.
Indications for use:
♦ overdose of opioids;
♦ depression of the respiratory center caused by opioids;
♦ to restore respiration in newborns after administration of opioid analgesics
in recently delivered women;
♦ as a diagnostic agent in patients with suspected opioid dependence;
♦ postoperative administration; for acceleration of postanesthetic recovery before the end of controlled breathing. The medicinal product is used
postoperatively only if opioid analgesics were used during anesthesia. Naloxone
is not effective in treating respiratory depression caused by substances other
Shelf life: 4 years.